If Leronlimab prevents cancer metastasis (even hal
Post# of 148282
(Total Views: 704)
Posted On: 07/15/2019 1:02:31 AM
Re: Evil Rabbit #4859
If Leronlimab prevents cancer metastasis (even half as well as it does in the mouse model) the numbers are staggering. At just $35,000 per patient 500,000 is $17.5 billion in revenue just in the US. If only 10% market it is still $1.75 billion per year! At a 10X valuation would be $17.5 billion divided by 700,000 shares would be $25 per share. Why on earth would anyone short this stock?
(0)
(0)CytoDyn Inc (CYDY) Stock Research Links
Scroll down for more posts ▼